SLC22A12 and hyperuricemia: In addition to resveratrol, Chen et al. found that the resveratrol tetramer (20–60 mg/kg) could also inhibit URAT1 activity and promote uric acid excretion in mice with potassium oxonate induced hyperuricemia mice [77].